QuidelOrtho vs Qiagen
QDEL and QGEN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How QDEL and QGEN compare
Qiagen grew revenue faster over the last twelve months (5.7% versus −2.5% for QuidelOrtho).
Qiagen keeps more of each dollar of sales as profit, with a net margin of 20.3% compared with −39.2% at QuidelOrtho.
Qiagen scores higher on the StockData Score (10 against 6 for QuidelOrtho), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | QDEL | QGEN |
|---|---|---|
| Size and price | ||
| Market cap | $909M | – |
| Share price | $13.25 | $50.22 |
| Change, 1 year | −52.6% | 1.1% |
| Change, 5 years | −89.1% | −12.0% |
| Beta (5Y) | 0.85 | 0.69 |
| Employees | 6,500 | 5,700 |
| StockData Score | ||
| Total score | 6 | 10 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 2 | 4 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× | – |
| P/B | 0.5× | – |
| FCF yield | −23.2% | – |
| Fair value | $84.25 | – |
| Margin of safety | 84.3% | – |
| Growth | ||
| Revenue growth (TTM) | −2.5% | 5.7% (better) |
| Revenue growth, 5Y average | 10.4% (better) | 2.2% |
| Net income growth (TTM) | – | 408% |
| EPS growth (TTM) | – | 424% |
| EPS growth, 5Y average | – | 4.9% |
| Profitability | ||
| Gross margin | 44.6% | 62.2% (better) |
| Operating margin | −30.8% | 22.3% (better) |
| Net margin | −39.2% | 20.3% (better) |
| FCF margin | −7.9% | 21.7% (better) |
| Return on equity | −45.9% | 11.6% (better) |
| Return on invested capital | −13.3% | 9.9% (better) |
| Financial health | ||
| Debt / equity | 1.63 | 0.44 (better) |
| Net debt / EBITDA | – | 0.84 |
| Interest coverage | −4.1× | 14.0× (better) |
| Current ratio | 1.39 | 3.90 (better) |
| Altman Z-score | −0.08 | – |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Payout ratio | – | 12.8% |
| Years of dividend growth | – | 0 |
| Buyback yield | −0.57% | – |
| Shareholder yield | −0.57% | – |
| Ownership | ||
| Held by institutions | 121% | 67.4% |
| Held by insiders | 43.4% | 0.00% |
| Insider net buying, 12 months | $1.2M | – |
| Short interest, % of float | 38.5% | 3.5% |
Go deeper
- QDEL stock overview
- QDEL income statement
- QDEL valuation and score
- QGEN stock overview
- QGEN income statement
- QGEN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.